Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study

Published:2020-05-30 Issue:14 Volume:9 Page:5134-5142
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Chang Jianhua¹,Chen Gongyan²,Wang Dong³,Wang Guihua⁴,Lu Shun⁵,Feng Jifeng⁶,Li Wei⁷,Li Ping⁸,Lanzarotti Corinna⁹,Chessari Salvatore⁹,Zhang Li¹⁰^ORCID

Affiliation:

1. Fudan University Shanghai Cancer Center Shanghai China

2. Affiliated Tumour Hospital of Harbin Medical University Harbin China

3. The Third Affiliated Hospital of Third Military Medical University Chongqing China

4. Changsha Central Hospital Changsha China

5. Shanghai Chest HospitalShanghai Jiao Tong University Shanghai China

6. Jiangsu Cancer HospitalNanjing Medical University Affiliated Cancer Hospital Nanjing China

7. The First Affiliated Hospital of Jilin University Changchun China

8. West China School of Medicine West China Hospital Sichuan University Chengdu China

9. Helsinn Healthcare Lugano Switzerland

10. Sun Yat‐sen University Cancer Center Guangzhou China

Funder

Helsinn Healthcare

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3123

Reference26 articles.

1. Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting

2. ASCO 50th anniversary poll names top 5 advances past 50 years. The ASCO Post October 15 2014.

3. The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)

4. Antiemetic Guideline Consistency and Incidence of Chemotherapy-Induced Nausea and Vomiting in US Community Oncology Practice: INSPIRE Study

5. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study;Journal of Clinical Medicine;2024-02-01

2. 2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents;Supportive Care in Cancer;2023-12-21

3. Retrospective Evaluation of a Dexamethasone Sparing Antiemetic Regimen: An Antiemetic Prophylaxis Study on NEPA (Netupitant Plus Palonosetron) for Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients;Cureus;2023-11-30

4. A deep learning‐based interpretable decision tool for predicting high risk of chemotherapy‐induced nausea and vomiting in cancer patients prescribed highly emetogenic chemotherapy;Cancer Medicine;2023-08-23

5. Chinese expert consensus on prevention and treatment of delayed nausea and vomiting (2022 Edition);Oncology and Translational Medicine;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3